000 | 02426na a2200313 4500 | ||
---|---|---|---|
003 | H12O | ||
005 | 20210625062807.0 | ||
008 | 130622s2012 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_9867 _aBarrado Blanco, Laura _eMicrobiología y Parasitología |
||
100 |
_978 _aChaves Sánchez, Fernando _eMicrobiología y Parasitología |
||
100 |
_91619 _aOrellana Miguel, María Ángeles _eMicrobiología y Parasitología |
||
100 |
_9868 _aRodríguez Otero, Joaquín _eMicrobiología y Parasitología |
||
100 |
_91506 _aSanz Sanz, Francisca _eMicrobiología y Parasitología |
||
100 |
_aViedma Moreno, Esther _91616 _eInstituto de Investigación i+12 |
||
100 |
_aVilla García, Jennifer _92027 _eMicrobiología y Parasitología |
||
245 | 0 | 0 |
_aVIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain. _h[artículo] |
260 |
_bEmerging Infectious Diseases, _c2012 |
||
300 | _a18(8):1235-41. | ||
500 | _aFormato Vancouver: Viedma E, Juan C, Villa J, Barrado L, Orellana MA, Sanz F, et al. VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain. Emerg Infect Dis. 2012 Aug;18(8):1235-41. | ||
501 | _aPMID: 22840969 | ||
504 | _aContiene 37 referencias | ||
520 | _aA total of 183 patients were colonized or infected with multidrug-resistant Pseudomonas aeruginosa isolates at a hospital in Spain during 2007-2010; prevalence increased over this period from 2.8% to 15.3%. To characterize these isolates, we performed molecular epidemiologic and drug resistance analysis. Genotyping showed that 104 (56.8%) isolates belonged to a single major clone (clone B), which was identified by multilocus sequence typing as sequence type (ST) 175. This clone was initially isolated from 5 patients in 2008, and then isolated from 23 patients in 2009 and 76 patients in 2010. PCR analysis of clone B isolates identified the bla(VIM-2) gene in all but 1 isolate, which harbored bla(IMP-22). ST175 isolates were susceptible to only amikacin (75%) and colistin (100%). Emergence of the ST175 clone represents a major health problem because it compromises therapy for treatment of P. aeruginosa nosocomial infections. | ||
710 |
_981 _aServicio de Microbiología y Parasitología |
||
710 |
_9625 _aInstituto de Investigación imas12 |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/8/pc8274.pdf _ySolicitar documento |
||
942 |
_n0 _2ddc _cART |
||
999 |
_c8274 _d8274 |